Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > SZLS MANAGEMENT LACKS CAPACITY
View:
Post by Stockish12 on Jan 07, 2021 8:48pm

SZLS MANAGEMENT LACKS CAPACITY

There are some very daft investors on this platform.
We will be lucky if Tripp delivers a $10million revenue from Aristotle but some clowns on here talking about billion dollar valuations. LMFAO 
Have you seen CEOs and board members of billion dollar companies? Do they sound incoherent and look like Tripp?
What a joke.

We will be lucky if this stock ever sets a new 52wk high.

Tripp is a joke. 

My advice. Be prepared for Tripp telling you Aristotle is further delayed (this would not be new). Have money on hand to average down some more if the Dec fins come out before Aristotle cos it will be trash as usual.

I sent Tripp and the IR an email for them to consider a replacement for Tripp as CEO. That dude does not have the capacity to achieve much for this company.

Did you all see CBDT PR? talking to airlines for their covid test kits?

SZLS made its saliva testing since October and its in achieved nothing. CBDT already got $5.5million in a shorter time for their home testing kit and trying to get major deals with airlines.

Same way SZLS could not market covid tests is the same way they will have a good product like aristotle but not know how to market it.
Comment by jp1989 on Jan 07, 2021 9:12pm
very convincing
Comment by bogeyfree on Jan 07, 2021 9:27pm
Don't know about convincing but certainly not very uplifting and sadly, Stockish12 has not been proven wrong yet and it's a bit scary and very frustrating to see the SP sitting at .72.
Comment by Stockish12 on Jan 08, 2021 12:44am
At the last conference call, Tripp mentioned the two companies on Nasdaq that Szls can be compared to but Szls product is better. I cant remember their names. I looked them up after the call. Their CEOs are well-seasoned businessmen and obviously understand the financial market perfectly. Tripp knows the product (I hope) but he is not business savy. He cannot achieve what any of those two ...more  
Comment by Boomer51 on Jan 08, 2021 7:43am
I think u should do a bit more DD and check out Rory Riggs on the board of directors!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities